| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Chief Executive Officer
1 company
Dube Eric M serves as a Chief Executive Officer at TVTX. Across recent SEC filings that breaks down to 0 buys and 56 sells. Those positions are worth an estimated $3.9M at current prices.
Historically, Dube Eric M's trades have earned a middling insider score of 56/100 across 23 rated trades. Over a 12-month horizon, 47.4% of those trades were profitable, with an average 12-month return of -17.8%.
The biggest single holding is TVTX (~$3.9M) as Chief Executive Officer. The recent filings there lean toward selling, a net 1,393,081 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 15, 2026 | TVTX Travere Therapeutics, Inc. | Chief Executive Officer | Sale+OE10b5-1 | 243,735 | $53.82 | $13,116,670.65 | -36.0% | - | - | |
| Sep 17, 2026 | TVTX Travere Therapeutics, Inc. | Chief Executive Officer | Sale+OE10b5-1 | 400,000 | $63.48 | $25,390,729.21 | -48.0% | - | - | |
| May 6, 2026 | TVTX Travere Therapeutics, Inc. | Chief Executive Officer | Sale+OE10b5-1 | 22,500 | $43.95 | $988,875.00 | -4.9% | +25.2% | - | |
| Apr 15, 2026 | TVTX Travere Therapeutics, Inc. | Chief Executive Officer | Sell10b5-1 | 64,000 | $41.09 | $2,629,975.10 | -12.9% | +39.3% | - | |
| Apr 1, 2026 | TVTX Travere Therapeutics, Inc. | Chief Executive Officer | Sale+OE10b5-1 | 60,000 | $30.93 | $1,855,839.18 | -12.2% | +80.8% | - | |
| Feb 20, 2026 | TVTX Travere Therapeutics, Inc. | Chief Executive Officer | Sale+OE10b5-1 | 60,000 | $30.10 | $1,805,766.00 | -12.2% | +47.2% | - | |
| Feb 3, 2026 | TVTX Travere Therapeutics, Inc. | Chief Executive Officer | Sell10b5-1 | 100,087 | $32.28 | $3,230,315.62 | -18.8% | +36.8% | - | |
| Jan 27, 2026 | TVTX Travere Therapeutics, Inc. | Chief Executive Officer | Sale+OE10b5-1 | 60,000 | $30.09 | $1,805,134.22 | -12.5% | +35.9% | - | |
| Oct 29, 2025 | TVTX Travere Therapeutics, Inc. | Chief Executive Officer | Sale+OE10b5-1 | 120,000 | $30.32 | $3,638,432.15 | -22.3% | +0.2% | - | |
| May 5, 2025 | TVTX Travere Therapeutics, Inc. | Chief Executive Officer | Sale+OE10b5-1 | 18,924 | $21.05 | $398,350.20 | -4.3% | -25.5% | +109.2% |